Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Frizzled class receptor 4 (FZD4) mRNA 3' untranslated region (3'UTR) is a non-coding sequence located at the 3-prime end of the FZD4 messenger RNA, serving as a primary site for post-transcriptional regulation. This region contains multiple seed sequences for microRNAs (miRNAs), including miR-101, miR-224, and miR-506, which bind to the 3'UTR to negatively regulate FZD4 protein levels through mRNA cleavage or translational repression (PubMed: 30603482, 27121318). FZD4 itself is a key component of the Wnt/beta-catenin signaling pathway, essential for angiogenesis and tissue homeostasis, particularly in the retina (UniProt: Q9ULV1). In various malignancies, such as bladder cancer and hepatocellular carcinoma, the downregulation of specific miRNAs leads to the stabilization of FZD4 mRNA via its 3'UTR, resulting in receptor overexpression that drives tumor progression and metastasis (PubMed: 25193394). Consequently, the FZD4 mRNA 3'UTR is an emerging focal point for RNA-targeted therapeutic strategies, such as miRNA mimics designed to restore endogenous silencing mechanisms. While no clinical drugs currently target this specific UTR, it remains a significant biomarker for disease prognosis and a potential site for precision medicine interventions using antisense technologies. The structural integrity of this region is also vital, as variations can influence the binding affinity of regulatory proteins and RNAs, thereby impacting the overall Wnt signaling output. Therapeutic challenges include the precise delivery of RNA-based agents to target tissues and the avoidance of off-target effects on other transcripts sharing similar regulatory motifs.
MicroRNA-mediated gene silencing and translational repression
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Frizzled class receptor 4 mRNA 3' untranslated region (FZD4 mRNA 3'UTR).